Franciscus Gasthuis & Vlietland in Rotterdam has fitted extra EarlySense units in its newly expanded 12-bed pulmonary department.

The expansion follows the successful implementation in 2018 of EarlySense’s continuous monitors in the hospital’s 28-bed pulmonology ward. This has assisted with early detection of and prevention of adverse events, such as code blue events resulting from cardiac or respiratory arrest and preventable ICU transfers. 

It also follows the successful application of the monitoring units to care for COVID-19 patients at Sheba Hospital in Israel, as well as other installations in more than 40,000 patient beds across global healthcare facilities.

“We’re dedicated to providing our patients with the highest level of care, and equipping our nursing staff with advanced technology to help them succeed in their roles,” said Lex Kahlmann, care manager pulmonology at Franciscus Gasthuis & Vlietland.

EarlySense’s contact-free continuous monitoring (CFCM) system is reported to track more than 100 patient data points per minute, including respiratory rate, heart rate and movement, without ever touching the patient. The sensor, placed under the patient’s mattress, transmits real-time patient data for the early detection of clinical changes to a display outside of the patient’s room, limiting the need for staff to gown up and enter isolation areas, says the company. 

As a contact-free monitoring solution, there are no leads or other wearable devices to adjust or to touch the patient’s body. Health staff are alerted to changes in patient vital signs, says the company, and they receive real-time alerts that enable earlier identification and prevention of potentially harmful events.

“For over a decade, contact-free continuous monitoring has helped care teams around the world identify real-time changes in patient condition to improve care and safety,” said Matt Johnson, chief executive of EarlySense. 

“Together with our local partner, Devices4Care, we’re proud to provide Franciscus Gasthuis & Vlietland with clinically proven technology to remotely and safely care for COVID-19 patients. EarlySense is excited to offer our technology to additional facilities around the world in an effort to protect healthcare workers and patients in the global fight against COVID-19.”